Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion description "[The DNA hypomethylating drug decitabine (DAC) reactivates silenced gene expression in cancer and is approved for the treatment of the myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion evidence source_evidence_literature NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion SIO_000772 20713525 NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion wasDerivedFrom befree-20140225 NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_assertion wasGeneratedBy ECO_0000203 NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP685896.RAluXxCy0FtVlmnMgEUrTicWII7xLR-0bQ-qs1IIFDjuE130_provenance.